Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver. 1978

T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
April 1988, Naunyn-Schmiedeberg's archives of pharmacology,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
September 1968, The American journal of physiology,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
January 1965, Journal of lipid research,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
March 1979, Toxicology and applied pharmacology,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
January 1971, Acta pharmacologica et toxicologica,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
March 1974, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
July 1965, Annals of the New York Academy of Sciences,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
December 2012, Phytotherapy research : PTR,
T Inaba, and T Umeda, and L Endrenyi, and W A Mahon, and W Kalow
January 1957, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!